Pathophysiology of pulmonary function anomalies in COVID-19 survivors

Pierantonio Laveneziana, Lucile Sesé, Thomas Gille

Source: Breathe, 17 (3) m3249; 10.1183/20734735.0065-2021
Journal Issue: September

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Pierantonio Laveneziana, Lucile Sesé, Thomas Gille. Pathophysiology of pulmonary function anomalies in COVID-19 survivors. Breathe, 17 (3) m3249; 10.1183/20734735.0065-2021

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Right ventricular function in infants with bronchopulmonary dysplasia: Association with respiratory sequelae
Source: International Congress 2016 – Neonatal and paediatric multiorgan manifestations of acute and chronic pulmonary disease and use of treatments
Year: 2016

Pulmonary function and functional capacity in survivors of severe acute respiratory syndrome
Source: Eur Respir J 2004; 24: Suppl. 48, 239s
Year: 2004

Pulmonary function and physical capacity in children with congenital heart disease
Source: International Congress 2018 – The value of lung function testing in various pathophysiological conditions
Year: 2018


Predicting the risk of respiratory distress in newborns with congenital pulmonary malformations
Source: Eur Respir J, 59 (2) 2100949; 10.1183/13993003.00949-2021
Year: 2022



Assessment of pulmonary function after partial lung resection due to pulmonary malformation in young children
Source: Eur Respir J 2003; 22: Suppl. 45, 129s
Year: 2003

Which is the utility of respiratory function tests in infants with congenital lung malformations?
Source: Eur Respir J 2005; 26: Suppl. 49, 614s
Year: 2005

Correction of endothelial dysfunction in patients with pulmonary diseases
Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases
Year: 2008


Echocardiographic indices of right ventricular function in pediatric pulmonary hypertension
Source: International Congress 2016 – Pulmonary hypertension in lung disease
Year: 2016

Prognostic value of right ventricular function in patients with severe pulmonary hypertension associated with respiratory disease
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013

Differences in pulmonary function tests between acute respiratory distress syndrome of pulmonary and extrapulmonary etiology
Source: Annual Congress 2011 - Intensive care outcome
Year: 2011


Hemodynamic assessment of pulmonary hypertension in corrected versus non-corrected grown-up congenital heart disease
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II
Year: 2013

Changes of lung function in infants with congenital heart disease and univentricular circulation
Source: Eur Respir J 2004; 24: Suppl. 48, 159s
Year: 2004

Lung function in children with congenital heart disease
Source: International Congress 2018 – Insights in primary ciliary dyskinesia, asthma and lung function testing
Year: 2018

Impact on survival of pulmonary function abnormalities in pulmonary arterial hypertension
Source: Annual Congress 2009 - Pulmonary hypertension
Year: 2009

Diffuse pulmonary development disorders- Molecular definable causes of pulmonary hypertension in the mature newborn
Source: International Congress 2015 – Neonatal and paediatric intensive care
Year: 2015


Congenital lung abnormalities
Source: Eur Respir Mon; 2010: 47: 263–276
Year: 2010

Echocardiographic assessment of cardiac function in patients with chronic obstructive pulmonary disease
Source: International Congress 2015 – COPD: interesting notes
Year: 2015

Pathophysiology of the pulmonary circulation
Source: International Congress 2016 – PG17 Pulmonary haemodynamics during exercise
Year: 2016